Tygacil (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Tygacil drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | TIGECYCLINE |
| SUBSTANCE NAME: | TIGECYCLINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Tygacil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tygacil from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/5mL) |
| START MARKETING DATE: | 2005-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-4990_0129f084-5a59-4282-b27b-3f2dd31381fa |
| PRODUCT NDC: | 0008-4990 |
| APPLICATION NUMBER: | NDA021821 |
Other TIGECYCLINE Pharmaceutical Manufacturers / Labelers:
